Spectrum of fibrotic lung diseases
M Wijsenbeek, V Cottin - New England Journal of Medicine, 2020 - Mass Medical Soc
Pulmonary Fibrotic Diseases This review covers fibrotic pulmonary diseases. Although
idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases …
idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases …
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
V Cottin, NA Hirani, DL Hotchkin… - European …, 2018 - Eur Respiratory Soc
Although these conditions are rare, a proportion of patients with interstitial lung diseases
(ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated …
(ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated …
A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality
C Hyldgaard, O Hilberg, AB Pedersen… - Annals of the …, 2017 - ard.bmj.com
Objectives To compare mortality risks in patients with rheumatoid arthritis-associated
interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort …
interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort …
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis
GM Joy, OA Arbiv, CK Wong, SD Lok… - European …, 2023 - Eur Respiratory Soc
Introduction Interstitial lung disease (ILD) is a frequent manifestation of connective tissue
disease (CTD) with substantial variability in prevalence and outcomes reported across CTD …
disease (CTD) with substantial variability in prevalence and outcomes reported across CTD …
Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
Background Idiopathic interstitial pneumonias are often complicated by pulmonary
hypertension, increasing morbidity and mortality. There are no approved treatments for …
hypertension, increasing morbidity and mortality. There are no approved treatments for …
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
AL Olson, AH Gifford, N Inase… - European Respiratory …, 2018 - Eur Respiratory Soc
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has
increased over recent years, but information on the prevalence and incidence of ILDs of …
increased over recent years, but information on the prevalence and incidence of ILDs of …
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
C Ye, S Cai, G Shen, H Guan, L Zhou, Y Hu… - Annals of the …, 2020 - ard.bmj.com
Objective The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-
19) have not been reported. This study aimed to describe the clinical features of COVID-19 …
19) have not been reported. This study aimed to describe the clinical features of COVID-19 …
Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations
T Shao, X Shi, S Yang, W Zhang, X Li, J Shu… - Frontiers in …, 2021 - frontiersin.org
Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …
Acute exacerbation of interstitial lung disease associated with rheumatic disease
F Luppi, M Sebastiani, C Salvarani… - Nature Reviews …, 2022 - nature.com
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients
C Fernández-Díaz, J Loricera, S Castañeda… - Seminars in arthritis and …, 2018 - Elsevier
Objective Interstitial lung disease (ILD) is one of the most serious complications of
rheumatoid arthritis (RA). In the present study, we aimed to assess the efficacy of abatacept …
rheumatoid arthritis (RA). In the present study, we aimed to assess the efficacy of abatacept …